The purpose of this pilot study was to explore the impact of pharmacist-provided\nrecommendations to general practitioners (GPs) of patients living in assisted living facilities (ALFs).\nA secondary objective of this study was to explore prescriber and ALF staff perceptions. This was a\nmixed-method, quasi experimental 1-group pre/post-test study with an explanatory qualitative arm\nusing in-depth semi-structured interviews at five regional ALFs and one independent community\npharmacy in East Tennessee. Residents older than 65 years of age, with confirmed diagnosis of Type\nII diabetes in the pharmacyâ??s medical record, taking anti-diabetic medication for at least 14 days and\nresident of affiliated ALF for at least past 30 days were enrolled. Phase 1 demonstrated a 35.1%\n(13/37 recommendations) acceptance rate of pharmacist recommendations. Phase 2 demonstrated a\nsimilar 31.3% acceptance rate of pharmacist recommendations (5/16 recommendations). The mean\npre-post difference in average 30-day FBG was greater in the accepted group than the rejected\nrecommendation group (-9.1 vs. -2.3 mg/dL). Pharmacist-GP collaboration in the ALF population\nwas feasible and may improve the quality of patient care of these residents.
Loading....